Antibody–drug conjugates as novel anti-cancer chemotherapeutics
C Peters, S Brown - Bioscience reports, 2015 - portlandpress.com
Over the past couple of decades, antibody–drug conjugates (ADCs) have revolutionized the
field of cancer chemotherapy. Unlike conventional treatments that damage healthy tissues …
field of cancer chemotherapy. Unlike conventional treatments that damage healthy tissues …
Antibody-drug conjugates as novel anti-cancer chemotherapeutics.
C Peters, S Brown - Bioscience Reports, 2015 - europepmc.org
Over the past couple of decades, antibody–drug conjugates (ADCs) have revolutionized the
field of cancer chemotherapy. Unlike conventional treatments that damage healthy tissues …
field of cancer chemotherapy. Unlike conventional treatments that damage healthy tissues …
[PDF][PDF] Antibody–drug conjugates as novel anti-cancer chemotherapeutics
C Peters, S Brown - cyberleninka.org
Over the past couple of decades, antibody–drug conjugates (ADCs) have revolutionized the
field of cancer chemotherapy. Unlike conventional treatments that damage healthy tissues …
field of cancer chemotherapy. Unlike conventional treatments that damage healthy tissues …
Antibody–drug conjugates as novel anti-cancer chemotherapeutics
C Peters, S Brown - Bioscience Reports, 2015 - cir.nii.ac.jp
抄録< jats: p> Over the past couple of decades, antibody–drug conjugates (ADCs) have
revolutionized the field of cancer chemotherapy. Unlike conventional treatments that …
revolutionized the field of cancer chemotherapy. Unlike conventional treatments that …
[PDF][PDF] Antibody-drug conjugates as novel anti-cancer chemotherapeutics
C Peters, S Brown - 2015 - Citeseer
Over the past couple of decades, antibody drug conjugates (ADCs) have revolutionized the
field of cancer chemotherapy. Unlike conventional treatments that damage healthy tissues …
field of cancer chemotherapy. Unlike conventional treatments that damage healthy tissues …
Antibody-drug conjugates as novel anti-cancer chemotherapeutics.
C Peters, S Brown - Bioscience Reports, 2015 - search.ebscohost.com
Over the past couple of decades, antibody-drug conjugates (ADCs) have revolutionized the
field of cancer chemotherapy. Unlike conventional treatments that damage healthy tissues …
field of cancer chemotherapy. Unlike conventional treatments that damage healthy tissues …
[HTML][HTML] Antibody–drug conjugates as novel anti-cancer chemotherapeutics
C Peters, S Brown - Bioscience Reports, 2015 - ncbi.nlm.nih.gov
Over the past couple of decades, antibody–drug conjugates (ADCs) have revolutionized the
field of cancer chemotherapy. Unlike conventional treatments that damage healthy tissues …
field of cancer chemotherapy. Unlike conventional treatments that damage healthy tissues …
Antibody-drug conjugates as novel anti-cancer chemotherapeutics
C Peters, S Brown - Bioscience reports, 2015 - pubmed.ncbi.nlm.nih.gov
Over the past couple of decades, antibody-drug conjugates (ADCs) have revolutionized the
field of cancer chemotherapy. Unlike conventional treatments that damage healthy tissues …
field of cancer chemotherapy. Unlike conventional treatments that damage healthy tissues …
[PDF][PDF] Antibody–drug conjugates as novel anti-cancer chemotherapeutics
C Peters, S Brown - pdfs.semanticscholar.org
Over the past couple of decades, antibody–drug conjugates (ADCs) have revolutionized the
field of cancer chemotherapy. Unlike conventional treatments that damage healthy tissues …
field of cancer chemotherapy. Unlike conventional treatments that damage healthy tissues …
Antibody-drug conjugates as novel anti-cancer chemotherapeutics.
C Peters, S Brown - Bioscience Reports, 2015 - europepmc.org
Over the past couple of decades, antibody–drug conjugates (ADCs) have revolutionized the
field of cancer chemotherapy. Unlike conventional treatments that damage healthy tissues …
field of cancer chemotherapy. Unlike conventional treatments that damage healthy tissues …